Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-Jan-23 8:56 PM View:  | Nabriva Therapeutics Plc (NBRV) | 29-Jan-23 | Payment of Exercise | 140 | $1.50 | $210.00 | (< 1%) 14.42K to 14.28K | |
| 10-Jan-23 5:58 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Jan-23 | Payment of Exercise | 5 | $1.30 | $6.50 | (< 1%) 14.43K to 14.42K | |
| 04-Jan-23 6:08 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Dec-22 | Payment of Exercise | 3 | $1.89 | $5.67 | (< 1%) 14.43K to 14.43K | |
| 08-Dec-22 4:37 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Dec-22 | Payment of Exercise | 4 | $2.02 | $8.08 | (< 1%) 14.44K to 14.43K | |
| 02-Dec-22 5:17 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Nov-22 | Payment of Exercise | 3 | $2.25 | $6.75 | (< 1%) 14.44K to 14.44K | |
| 08-Nov-22 5:26 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Nov-22 | Payment of Exercise | 4 | $2.24 | $8.96 | (< 1%) 14.44K to 14.44K | |
| 01-Nov-22 5:06 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Oct-22 | Payment of Exercise | 3 | $2.54 | $7.62 | (< 1%) 14.45K to 14.44K | |
| 11-Oct-22 5:00 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Oct-22 | Payment of Exercise | 4 | $2.72 | $10.88 | (< 1%) 14.45K to 14.45K | |
| 04-Oct-22 9:36 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Sep-22 | Payment of Exercise | 3 | $2.08 | $6.24 | (< 1%) 14.45K to 14.45K | |
| 07-Sep-22 5:57 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Sep-22 | Payment of Exercise | 89 | $0.16 | $13.94 | (< 1%) 361.4K to 361.31K | |
| 01-Sep-22 6:35 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Aug-22 | Payment of Exercise | 61 | $0.16 | $10.04 | (< 1%) 361.46K to 361.4K | |
| 08-Aug-22 5:45 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Aug-22 | Payment of Exercise | 89 | $0.18 | $16.44 | (< 1%) 361.55K to 361.46K | |
| 03-Aug-22 9:43 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jul-22 | Payment of Exercise | 61 | $0.18 | $10.92 | (< 1%) 361.61K to 361.55K | |
| 07-Jul-22 4:10 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Jul-22 | Payment of Exercise | 89 | $0.18 | $16.22 | (< 1%) 361.7K to 361.61K | |
| 01-Jul-22 6:06 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Jun-22 | Payment of Exercise | 61 | $0.18 | $11.10 | (< 1%) 361.76K to 361.7K | |
| 07-Jun-22 4:46 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Jun-22 | Payment of Exercise | 89 | $0.20 | $17.80 | (< 1%) 361.85K to 361.76K | |
| 02-Jun-22 4:09 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-May-22 | Payment of Exercise | 61 | $0.21 | $12.60 | (< 1%) 361.91K to 361.85K | |
| 09-May-22 6:33 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-May-22 | Payment of Exercise | 89 | $0.26 | $23.14 | (< 1%) 362.0K to 361.91K | |
| 03-May-22 4:58 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Apr-22 | Payment of Exercise | 61 | $0.31 | $18.91 | (< 1%) 362.06K to 362.0K | |
| 08-Apr-22 4:15 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Apr-22 | Payment of Exercise | 89 | $0.41 | $36.49 | (< 1%) 362.15K to 362.06K | |
| 04-Apr-22 6:26 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Mar-22 | Payment of Exercise | 61 | $0.42 | $25.62 | (< 1%) 362.21K to 362.15K | |
| 08-Mar-22 4:14 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Mar-22 | Payment of Exercise | 89 | $0.43 | $38.27 | (< 1%) 362.3K to 362.21K | |
| 02-Mar-22 7:50 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Feb-22 | Payment of Exercise | 61 | $0.45 | $27.45 | (< 1%) 362.36K to 362.3K | |
| 08-Feb-22 4:26 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Feb-22 | Payment of Exercise | 106 | $0.48 | $50.88 | (< 1%) 362.47K to 362.36K | |
| 01-Feb-22 8:44 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jan-22 | Payment of Exercise | 73 | $0.48 | $35.04 | (< 1%) 362.54K to 362.47K | |
| 01-Feb-22 8:44 PM View: | Nabriva Therapeutics Plc (NBRV) | 29-Jan-22 | Payment of Exercise | 3,483 | $0.45 | $1,567.35 | (< 1%) 366.02K to 362.54K | |
| 10-Jan-22 4:18 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Jan-22 | Payment of Exercise | 110 | $0.58 | $63.80 | (< 1%) 366.13K to 366.02K | < 1% |
| 04-Jan-22 5:05 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Dec-21 | Payment of Exercise | 63 | $0.60 | $37.80 | (< 1%) 366.2K to 366.13K | (23%) |
| 08-Dec-21 5:13 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Dec-21 | Payment of Exercise | 92 | $0.72 | $66.24 | (< 1%) 366.29K to 366.2K | (< 1%) |
| 02-Dec-21 6:28 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Nov-21 | Payment of Exercise | 63 | $0.78 | $49.14 | (< 1%) 366.35K to 366.29K | 9% |
| 09-Nov-21 5:36 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Nov-21 | Payment of Exercise | 92 | $1.33 | $122.36 | (< 1%) 366.44K to 366.35K | 2% |
| 01-Nov-21 7:50 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Oct-21 | Payment of Exercise | 63 | $1.15 | $72.45 | (< 1%) 366.51K to 366.44K | 0% |
| 08-Oct-21 4:41 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Oct-21 | Payment of Exercise | 92 | $1.08 | $99.36 | (< 1%) 366.6K to 366.51K | (4%) |
| 04-Oct-21 4:09 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Sep-21 | Payment of Exercise | 63 | $1.19 | $74.97 | (< 1%) 366.66K to 366.6K | 0% |
| 08-Sep-21 5:25 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Sep-21 | Payment of Exercise | 93 | $1.11 | $103.23 | (< 1%) 366.75K to 366.66K | 3% |
| 02-Sep-21 10:00 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Aug-21 | Payment of Exercise | 63 | $1.06 | $66.78 | (< 1%) 366.82K to 366.75K | (5%) |
| 10-Aug-21 5:15 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Aug-21 | Payment of Exercise | 92 | $1.17 | $107.64 | (< 1%) 366.91K to 366.82K | 3% |
| 03-Aug-21 4:07 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jul-21 | Payment of Exercise | 63 | $1.10 | $69.30 | (< 1%) 366.97K to 366.91K | (5%) |
| 08-Jul-21 4:09 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Jul-21 | Payment of Exercise | 92 | $1.27 | $116.84 | (< 1%) 367.06K to 366.97K | 5% |
| 08-Jun-21 4:09 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Jun-21 | Payment of Exercise | 92 | $1.34 | $123.28 | (< 1%) 367.22K to 367.13K | (5%) |
| 02-Jun-21 4:10 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-May-21 | Payment of Exercise | 63 | $1.38 | $86.94 | (< 1%) 367.28K to 367.22K | (< 1%) |
| 10-May-21 5:52 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-May-21 | Payment of Exercise | 92 | $1.49 | $137.08 | (< 1%) 367.37K to 367.28K | 1% |
| 04-May-21 4:04 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Apr-21 | Payment of Exercise | 63 | $1.78 | $112.14 | (< 1%) 367.44K to 367.37K | 3% |
| 30-Apr-21 4:47 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Apr-21 | Grant | 290,697 | -- | -- | 379% 76.74K to 367.44K | |
| 08-Apr-21 9:47 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Apr-21 | Payment of Exercise | 92 | $1.73 | $159.16 | (< 1%) 76.83K to 76.74K | 3% |
| 02-Apr-21 6:14 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Mar-21 | Payment of Exercise | 63 | $1.66 | $104.58 | (< 1%) 78.09K to 78.03K | (5%) |
| 08-Apr-21 9:47 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Mar-21 | Payment of Exercise | 92 | $1.79 | $164.68 | (< 1%) 76.92K to 76.83K | 6% |
| 02-Mar-21 7:39 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Feb-21 | Payment of Exercise | 63 | $2.39 | $150.57 | (< 1%) 78.15K to 78.09K | 20% |
| 08-Apr-21 9:47 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Feb-21 | Payment of Exercise | 1,104 | $2.90 | $3,201.60 | (1%) 78.03K to 76.92K | 42% |
| 02-Feb-21 7:57 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jan-21 | Payment of Exercise | 75 | $2.62 | $196.50 | (< 1%) 78.23K to 78.15K |